Corporate Communication,Global Media and Press Releases,

Spokesperson European Communication,Communication advisory team.

Finance department Leadership and advisory committee.Annual Reports
drafting team.
Subsidiary Planning and Implementations, PharmaceuticalsAPI and
Chemicals Research and development.
Countries: EU –UK, Ireland, Poland, Germany, Austria, Romania,
Luxomburg, France
Africa –Kenya, South Africa, Ghana, Ivory Coast, Senegal
Russia & CIS –Moscow,Turkmenistan
Specialties: Pharmaceuticals Distribution and Market Launches, Pharma
Sales, financial consulting and corporate venture capital. International
Corporate Communications and Mass media management. Finance and
Accounting: Financial Management with broad experience in all aspects of
accounting, tax planning and auditing.
Others: Experience in Product Marketing, Pharma Recruitment,
Regulatory Submissions, Dossier Preparation, Qualifications and
Validations,WHO/GMP Audits,Compliance and RiskAssessment and R&D
Documentation.
Shantanu SinghTaj Pharma
Latest News & Videos

 Shantanu Kumar Singh is an

Indian businessman, Director
of Taj Pharma Group India. He
serves as a board member for
the Pharma Group companies
and is responsible for
managing the Pharma division
growth as a leading health
group aground the launched
markets.
Shantanu Kumar Singh – Director at
Taj Pharma Group and Leading
Business Consultant.

 Shantanu Kumar
Singh – Director
at Taj Pharma
Group and
Leading Business
Consultant.
Shantanu Kumar Singh is an Indian
businessman. Director at Taj Pharma
Group India. He serves as a board
member for the Group Indian companies
and is known for consulting Mumbai
entrepreneurs with innovative business
models in the financial capital. He has
been recognised by heading Alzheimer’s
disease drug trials for the UK market by
venturing a new drug discovery
subsidiary, Sienna Biotec India. Further,
he has been recognised to serve as a
board member of several Middle East
Ministry of Health boards to improve
healthcare in countries like Qatar, Tunisia
andYemen. Singh attained his education
at The Lawrence School, Sanawar, India.
He further moved to England for a degree
in Finance and Accounting at University of
Durham, United Kingdom. Singh holds
expertise in International subsidiary
planning, Implementation,
Pharmaceutical APIs, Chemicals Research
and Development.
Shantanu Kumar Singh is an Indian
businessman, Director of Taj Pharma Group
India. He serves as a board member for the
Pharma Group companies and is
responsible for managing the Pharma
division growth as a leading health group
aground the launched markets.
Shantanu Singh Taj Pharma
Latest News & Videos {Taj
Pharma} Shantanu Kumar Singh's
Executive Director Taj Pharma
Taj Pharmaceuticals Limited Shantanu Singh {Taj Pharma} Shantanu Kumar Singh's Executive Director Taj Pharma Group Shantanu
Kumar Singh, TAJ PHARMA - Company directors | Shantanu Kumar Singh is an Indian businessman, Director of Taj Pharma Group India.
He serves as a board member for the Pharma Group companies and is responsible for managing the Pharma division growth as a leading
health group aground the launched markets. Shantanu Kumar Singh is an Indian businessman. Director at Taj Pharma Group India. He
serves as a board member for the Group Indian companies and is known for consulting Mumbai entrepreneurs with innovative business
models in the financial capital. He has been recognised by heading Alzheimer disease drug trials for the UK market by venturing a new
drug discovery subsidiary, Sienna Biotec India. Further, he has been recognised to serve as a board member of several Middle East
Ministry of Health boards to improve healthcare in countries like Qatar, Tunisia and Yemen. Singh attained his education at The
Lawrence School, Sanawar, India. He further moved to England for a degree in Finance and Accounting at University of Durham, United
Kingdom. Singh holds expertise in International subsidiary planning, Implementation, Pharmaceutical APIs, Chemicals Research and
Development. Specialties: Finance and Accounting: Financial Expert with broad experience in all aspects of accounting, tax planning,
auditing and financial management. Experience in Pharmaceuticals, financial consulting and corporate venture capital. Finance Portfolio
Management and (BSE) IPO Advisory. International Corporate Communications and Mass media management. Experience | Executive
Director “ TAJ PHARMA GROUP Location: Global International Business Operations, Communication and International Conference,
Contract Manufacturing and Sales, Project Financial Forecasts and Planning, Corporate Capital Venturing, Bonds and Debenture
handling. Management Strategic Consulting including business plan & international sales strategy development. Corporate
Communication, Global Media and Press Releases, Spokesperson European Communication, Communication advisory team. Finance
department Leadership and advisory committee
Shantanu Kumar
Singh – Director at Taj
Pharma Group
 Specialties:
Finance and Accounting: Financial Expert with broad
experience in all aspects of accounting, tax planning,
auditing and financial management. Experience in
Pharmaceuticals, financial consulting and corporate
venture capital. Finance Portfolio Management and
(BSE) IPO Advisory. International Corporate
Communications and Mass media management.
 Experience
 Executive Director – TAJ PHARMA GROUP
Location: Global
 International Business Operations, Communication
and International Conference, Contract
Manufacturing and Sales, Project Financial
Forecasts and Planning, Corporate Capital
Venturing, Bonds and Debenture handling.
 Management Strategic Consulting including
business plan & international sales strategy
development.

Founder & CEO –TAJ
INFOTECH INC.
Location: Global
Knowledge is Key to today’s
Information Age, this is a New
Type of I.T. Firm, provides a full
range of innovative Web
presence products & services to
Web Hosts, Web Designers,
Technology Consultants and I.T
Resellers worldwide. Most
innovative cloud technology by
our global data centers based in
Austin, UK, India and Hong
Kong. more:
http://shop.tajinfotech.com/
 Creative Director – TAJ AGRO
Location: Mumbai Area, India
 Introducing New Products,
Business Re-modeling, Business
Restructuring, Recovery and
turnaround.
 Director Sales – Taj API
Location: Mumbai Area, India
 Taj Active Pharmaceutical
Ingredients (or Taj API) is an
international pharmaceutical
api company based in India. Taj
Api introduced Oseltamivir
Phosphate ( INN) which is drug
used for H5N1 avian influenza.
The company was first to
manufacture the raw martial for
such a cause in India.
  Successful executives are often hailed as superhuman, but the reality is
they’re regular people. Well, maybe not exactly!
 Given our unusual lifestyle of an entrepreneur, and that so many are fuelled by
Successful the promise of wild riches, it comes as no surprise that we all have an inspiring
stories about overcoming adversity.
executives are  Every business success stories is fraught with an eccentric leader, his personal
struggles, and uncommon lifestyles to find their place and translate their life
often hailed as experiences into success.
superhuman  After having some success as a generics formulator, I decided launching a
dedicated oncology division to reduce the patient costs.
Executive Director  So in 2013 after Completing at Durham University, England; Further pursued a
Taj Pharma, Bachelors and Masters in Indian Law, co-founded an IT firm Taj Infotech INC;
one of my most successful endeavors yet which is also fully automated
Pharmaceuticals, business with very little human intervention. “Prior to founding Taj Infotech, I
completed my degrees at Durham”.
S K Singh Taj  The extra workload didn’t stop me from innovating in Pharma Sector; I was
instrumental in creating some of the first generics into the Russian and African
Pharma, Shantanu markets. To this day, more than 35 million people all over the world have used
one of the company’s products.
Kumar Singh  “Sometimes, the best motivation is not what someone says to you – it’s what
you’ve experienced yourself.”
Tags: Shantanu kumar Singh executive director director taj Pharmaceuticals | shantanu kumar singh executive
director taj pharma | shantanu taj pharma | Successful executives | taj pharma | taj pharmaceutical | taj
pharmaceutical director | taj pharmaceutical news | taj pharmaceutical reviews
chemotherapy drugs, Director and CFO, dynamic entrepreneur, Pharmaceuticals, Russia’s pharma, S K Singh Taj Pharma, Shantanu Kumar Singh, taj pharma industry, taj pharma news, Taj Pharmaceuticals Limited, Taj Pharmaceuticals Oncology

Trio of Indian
pharmaceutical
s millionaires
launched 130  Owners of Taj Pharmaceuticals have launched 130 innovative
oncology to increase patient access their options for
oncology chemotherapy drugs
generics [Taj
Pharma]-
chemotherapy
drugs

Mr.Shantanu Singh, Abhishek Singh, Priyanka Singh directors of Taj Pharmaceuticals Mumbai
Tags: chemotherapy drugs | Indian pharmaceuticals millionaires |
oncology generics | taj pharma | Taj Pharmaceuticals Limited | Trio of
Indian pharmaceuticals
 Indian pharmaceuticals businessmen Abhishek Singh, Taj Pharmaceuticals Limited and Priyanka Singh could be in for a major
windfall as one of Indian’s leading oncology care division manufacturing groups old unit is to be put up for sale in a deal that could
net its owners north of £2.5 million.

 This same in will lead to a further expansion of newly built Taj Oncology (chemotherapy drugs) Unit based in the Indian Territory;
Sources have not confirmed exact details of such new venture; However, the move could be looked at venturing in the regulated
This means it is less beholden to local markets of oncology products via an EMA, EU GMP regulated infrastructure with Oncology Section — Tablets, Capsules, Liquid and
authority funding, which has plummeted Lyophilized Injectables all under single unit.
in recent years, piling pressure on the  Sources confirmed a Press Association report yesterday that the owners of Taj Pharmaceuticals— including Dr.Ranveer Kumar Singh
wider sector. (Chairman), Mr Abhishek Singh (Director), Priyanks Singh and Shantanu Singh (Executive Director)— have mandated investment
Taj Pharmaceuticalschemotherapy banks and private equity holders to assess their options, the most likely of which is a sale.
divisionpaid off a £0.9 million debt five  The businessmen own Taj Pharmaceuticals Oncology Unit through their private investment vehicle Singh Investments SPA, and a
years ago through the sale and leaseback formal sale process could be kicked off within weeks.
of 2 Oncology care hospitals in Saint
 It is thought that several buyers have already expressed an interest, but only offers higher than £2.5 million are being taken seriously.
Petersburg to a property investment
business, Crosswell International, which  Dr.Ranvir Kumar Singh and Abhishek Singh (Director) and Priyanks Singh are close associates and have been involved in a number of
was backed by private investors at ventures together, including ownership of a stake in several pharmaceuticals manufacturing units which they sold in 2014.
Moscow.  Trio sibling directors are best known here for their involvement in Russia and CIS markets, mainly, Armenia, Azerbaijan, Belarus,
Labels: taj oncology, taj pharmaceutical Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russian Federation, Tajikistan, Turkmenistan, and Uzbekistan. Ms Priyanka Singh is one
of the partners behind Russia and CIS front, with more than 500 registered pharmaceutical products in state owned approx 1300–
chemotherapy division, taj oncology 1800 state owned pharmacies in CIS nations; which gives vast reach to the anti-cancer products and Mr Shantanu Singh for his
chemotherapy companies, ownership of national distribution channel cooperation’s “stazs” such based at Saint Petersburg.
Chemotherapy drugs—Taj
 Chemotherapy drug patients
Pharmaceuticals, taj chemotherapy
manufacturer, taj pharmaceutical  Taj Pharmaceuticals Oncology division currently boasts over 20 anti-cancer drug hospitals in Russia and CIS nations that house
Chemotherapy, taj pharmaceutical 11,000 chemotherapy patients people and employ 17,000 staff; who could be in severe drug shortage and budgetary constrains; if
such chemotherapy drugs has to be purchased from the open market at retain prices; making such chemotherapy centers to be non-
Chemotherapy, manufacturers of taj viable for poor and needy patients in India.
pharmaceuticals oncology, Taj
pharmaceuticals chemicals ApiAgro  Latest accounts filed with Ministry for Economic Developmentof the Russian Federation show that Taj Pharma Russia’s turnover
increased 5.3 per cent to £1.9 million in 2016, with operating profit coming in 5.6 per cent higher at £1.3 million.
Products, taj pharmaceutical oncology
india  The Indian pharmaceuticals trio Mr.Abhishek Singh, Mr.Shantanu Singh and Priyanka Singh first invested in Taj Pharmaceuticals
Oncology Division in 2004, a year after the company was set up by father Dr Ranvir Singh, and are in line for a bumper payday if a
deal goes ahead and a further expansion into bigger and better infrastructure with regulatory approvals.

 Its attraction to a potential buyer for old oncology division, likely to be a private equity firm, is the fact that Taj Pharma’s primary
focus is on privately-paying residents.